Determination of in vitro susceptibility of Candida species to amphotericin B by E-test and previously proposed MIC breakpoints on two different media;Candida türlerinin amfoterisin B'ye duyarlιlιǧιnιn E-test ve iki farklι besiyeri ile önerilmiş olan direnç sιnιr deǧerlerine göre araştιrιlmasι

Mikrobiyoloji Bulteni

Volumn 42, Issue 2, 2008, Pages 293-300

  Alp, Şehnaz ^a   Sancak, Banu ^a   Arikan, Sevtap ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Amphotericin B; Candida; E test; MIC breakpoint; Susceptibility

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT;

ARTICLE; CANDIDA; CULTURE MEDIUM; DRUG EFFECT; HUMAN; METHODOLOGY; MICROBIOLOGICAL EXAMINATION;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA; CULTURE MEDIA; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 52349086364     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Sterling TR, Gasser RA JR, Ziegler A. Emergence of resistance to amphotericin B during therapy for Candida glabrata infection in an immunocompetent host. Clin Infect Dis 1996; 23: 187-8.
2. Rex JH, Cooper CR Jr, Merz WG, Galgiani JN, Anaissie EJ. Detection of amphotericin B-resistant Candida isolates in a broth-based system. Antimicrob Agents Chemother 1995; 39: 906-9.
3. Ruhnke M, Eigler A, Tennagen I, Geiseler B, Engelmann E, Trautmann M. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J Clin Microbiol 1994; 32: 2092-8.
4. Chang HC, Chang JJ, Chan SH. et al. Evaluation of Etest for direct antifungal susceptibility testing of yeasts in positive blood cultures. J Clin Microbiol 2001; 39: 1328-33.
5. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved Standard. NCCLS Document M27-A2. 2002. NCCLS/CLSI, Wayne, Pa.
6. Wanger A, Mills K, Nelson PW, Rex JH. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates. Antimicrob Agents Chemother 1995; 39: 2520-2.
7. Pfaller MA, Messer SA. Bolmstrom A. Evaluation of Etest for determining in vitro susceptibility of yeast isolates to amphotericin B. Diagn Microbiol Infect Dis 1998; 32: 223-7.
8. Peyron J, Favel A, Michel-Nguyen A, Gilly M, Regli P, Bolmstrom A. Improved detection of amphotericin B-resistant isolates of Candida lusitaniae by Etest. J Clin Microbiol 2001; 39: 339-42.
9. Clancy CJ, Nguyen MH. Correlation between in vitro susceptibility determined by Etest and response to therapy with amphotericin B: results from a multicenter prospective study of candidemia. Antimicrob Agents Chemother 1999; 43: 1289-90.
10. Park BJ, Arthington-Skaggs BA, Hajjeh RA, et al. Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome. Antimicrob Agents Chemother 2006; 50: 1287-92.
11. http://www.doctorfungus.org
12. Krcmery V, Barnes AJ. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 2002; 50: 243-60.
13. Yang YL, Li SY, Cheng HH, Lo HJ. TSARY Hospitals. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002. Diagn Microbiol Infect Dis 2005; 51: 179-83.
14. Drutz DJ, Lehrer RI. Development of amphotericin B-resistant Candida tropicalis in a patient with defective leukocyte function. Am J Med Sci 1978; 276: 77-92.
15. Guinet R, Chanas J, Goullier A, Bonnefoy G, Ambroise-Thomas P. Fatal septicemia due to amphotericin B-resistant Candida lusitaniae. J Clin Microbiol 1983; 18: 443-4.
16. Safe LM, Safe SH, Subden RE, Morris DC. Sterol content and polyene antibiotic resistance in isolates of Candida krusei, Candida parakrusei, and Candida tropicalis. Can J Microbiol 1977; 23: 398-401.
17. Krogh-Madsen M, Arendrup MC, Heslet L, Knudsen JD. Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient. Clin Infect Dis 2006; 42: 938-44.
18. Loeffler J, Stevens DA. Antifungal drug resistance. Clin Infect Dis, 2003; 36: S31-41.